SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'J01'


List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YMX_B_CFXB1002_1
(BETA-LACTAMASE
CTX-M-9)		 2xfs ORF12
(Streptomyces
clavuligerus) 		6 / 12 LYS A 176
SER A 234
ASN A 236
LYS A 375
GLY A 377
SER A 378
 None
J01  A 600 (-3.4A)
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.49A 1ymxB-2xfsA:
22.6		 1ymxB-2xfsA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HW2_A_RFPA1200_1
(RIFAMPIN ADP-RIBOSYL
TRANSFERASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		6 / 12 PHE A 385
PHE A 276
ALA A 173
SER A 234
GLY A 316
LEU A 315
 J01  A 600 (-4.7A)
None
J01  A 600 ( 4.0A)
J01  A 600 (-3.4A)
None
None
 1.16A 2hw2A-2xfsA:
undetectable		 2hw2A-2xfsA:
15.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCT_D_ASDD1223_1
(GLUTATHIONE
S-TRANSFERASE A2)		 2xfs ORF12
(Streptomyces
clavuligerus) 		4 / 7 GLY A 414
LEU A 401
PHE A 385
PHE A 374
 J01  A 600 ( 4.7A)
None
J01  A 600 (-4.7A)
None
 1.01A 2vctD-2xfsA:
undetectable		 2vctD-2xfsA:
19.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XF3_A_J01A500_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		10 / 10 HIS A  84
TRP A  91
VAL A  93
ILE A 103
LEU A 362
LEU A 415
ARG A 418
GLY A 419
ALA A 422
LYS A 423
 J01  A 500 (-3.5A)
J01  A 500 (-4.6A)
None
None
None
None
J01  A 600 ( 2.8A)
J01  A 500 (-3.4A)
J01  A 500 (-3.4A)
J01  A 500 (-3.7A)
 0.14A 2xf3A-2xfsA:
67.5		 2xf3A-2xfsA:
99.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XF3_A_J01A600_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		10 / 11 LYS A  89
THR A 209
SER A 234
TYR A 359
ALA A 376
GLY A 377
SER A 378
MET A 383
PHE A 385
ARG A 418
 J01  A 600 (-2.8A)
J01  A 600 (-3.2A)
J01  A 600 (-3.4A)
J01  A 600 (-4.8A)
J01  A 600 (-3.5A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
J01  A 600 ( 3.9A)
J01  A 600 (-4.7A)
J01  A 600 ( 2.8A)
 0.12A 2xf3A-2xfsA:
67.5		 2xf3A-2xfsA:
99.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XF3_B_J01B500_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		9 / 9 HIS A  84
TRP A  91
VAL A  93
ILE A 103
LEU A 362
ARG A 418
GLY A 419
ALA A 422
LYS A 423
 J01  A 500 (-3.5A)
J01  A 500 (-4.6A)
None
None
None
J01  A 600 ( 2.8A)
J01  A 500 (-3.4A)
J01  A 500 (-3.4A)
J01  A 500 (-3.7A)
 0.26A 2xf3B-2xfsA:
65.6		 2xf3B-2xfsA:
99.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XF3_B_J01B600_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		10 / 11 LYS A  89
THR A 209
SER A 234
TYR A 359
ALA A 376
GLY A 377
SER A 378
MET A 383
PHE A 385
ARG A 418
 J01  A 600 (-2.8A)
J01  A 600 (-3.2A)
J01  A 600 (-3.4A)
J01  A 600 (-4.8A)
J01  A 600 (-3.5A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
J01  A 600 ( 3.9A)
J01  A 600 (-4.7A)
J01  A 600 ( 2.8A)
 0.15A 2xf3B-2xfsA:
65.6		 2xf3B-2xfsA:
99.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XH9_A_J01A1436_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		8 / 8 HIS A  84
TRP A  91
VAL A  93
LEU A 362
ARG A 418
GLY A 419
ALA A 422
LYS A 423
 J01  A 500 (-3.5A)
J01  A 500 (-4.6A)
None
None
J01  A 600 ( 2.8A)
J01  A 500 (-3.4A)
J01  A 500 (-3.4A)
J01  A 500 (-3.7A)
 0.14A 2xh9A-2xfsA:
68.5		 2xh9A-2xfsA:
99.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XH9_A_J01A1437_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		9 / 11 LYS A  89
THR A 209
SER A 234
TYR A 359
ALA A 376
GLY A 377
MET A 383
PHE A 385
ARG A 418
 J01  A 600 (-2.8A)
J01  A 600 (-3.2A)
J01  A 600 (-3.4A)
J01  A 600 (-4.8A)
J01  A 600 (-3.5A)
J01  A 600 ( 3.8A)
J01  A 600 ( 3.9A)
J01  A 600 (-4.7A)
J01  A 600 ( 2.8A)
 0.10A 2xh9A-2xfsA:
68.5		 2xh9A-2xfsA:
99.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XH9_A_J01A1437_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		5 / 11 SER A 378
THR A 209
ALA A 173
GLY A 377
ALA A 376
 J01  A 600 (-3.4A)
J01  A 600 (-3.2A)
J01  A 600 ( 4.0A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.5A)
 1.18A 2xh9A-2xfsA:
68.5		 2xh9A-2xfsA:
99.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XH9_B_J01B1436_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		9 / 9 HIS A  84
TRP A  91
VAL A  93
ILE A 103
LEU A 362
ARG A 418
GLY A 419
ALA A 422
LYS A 423
 J01  A 500 (-3.5A)
J01  A 500 (-4.6A)
None
None
None
J01  A 600 ( 2.8A)
J01  A 500 (-3.4A)
J01  A 500 (-3.4A)
J01  A 500 (-3.7A)
 0.26A 2xh9B-2xfsA:
65.6		 2xh9B-2xfsA:
99.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XH9_B_J01B1437_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		8 / 10 LYS A  89
THR A 209
SER A 234
TYR A 359
ALA A 376
GLY A 377
PHE A 385
ARG A 418
 J01  A 600 (-2.8A)
J01  A 600 (-3.2A)
J01  A 600 (-3.4A)
J01  A 600 (-4.8A)
J01  A 600 (-3.5A)
J01  A 600 ( 3.8A)
J01  A 600 (-4.7A)
J01  A 600 ( 2.8A)
 0.15A 2xh9B-2xfsA:
65.6		 2xh9B-2xfsA:
99.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2XH9_B_J01B1437_1
(ORF12)		 2xfs ORF12
(Streptomyces
clavuligerus) 		5 / 10 SER A 378
THR A 209
ALA A 173
GLY A 377
ALA A 376
 J01  A 600 (-3.4A)
J01  A 600 (-3.2A)
J01  A 600 ( 4.0A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.5A)
 1.20A 2xh9B-2xfsA:
65.6		 2xh9B-2xfsA:
99.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HLW_A_CE3A301_1
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		6 / 12 LYS A 176
SER A 234
ASN A 236
LYS A 375
GLY A 377
SER A 378
 None
J01  A 600 (-3.4A)
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.50A 3hlwA-2xfsA:
22.7		 3hlwA-2xfsA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HLW_B_CE3B302_1
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		5 / 12 SER A 234
ASN A 236
LYS A 375
GLY A 377
SER A 378
 J01  A 600 (-3.4A)
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.37A 3hlwB-2xfsA:
22.8		 3hlwB-2xfsA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HUO_A_PNNA300_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		5 / 12 LYS A 176
ASN A 236
LYS A 375
GLY A 377
SER A 378
 None
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.53A 3huoA-2xfsA:
22.5		 3huoA-2xfsA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HUO_B_PNNB301_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		5 / 12 LYS A 176
ASN A 236
LYS A 375
GLY A 377
SER A 378
 None
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.53A 3huoB-2xfsA:
22.7		 3huoB-2xfsA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q07_A_WPPA300_1
(BETA-LACTAMASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		6 / 12 LYS A 176
SER A 234
ASN A 236
LYS A 375
GLY A 377
SER A 378
 None
J01  A 600 (-3.4A)
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.55A 3q07A-2xfsA:
22.7		 3q07A-2xfsA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3Q07_B_WPPB400_1
(BETA-LACTAMASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		6 / 12 LYS A 176
SER A 234
ASN A 236
LYS A 375
GLY A 377
SER A 378
 None
J01  A 600 (-3.4A)
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.58A 3q07B-2xfsA:
22.8		 3q07B-2xfsA:
22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EUZ_A_MEMA401_1
(CARBAPENEM-HYDROLIZI
NG BETA-LACTAMASE
SFC-1)		 2xfs ORF12
(Streptomyces
clavuligerus) 		6 / 12 ALA A 173
LYS A 176
SER A 234
ASN A 236
LYS A 375
GLY A 377
 J01  A 600 ( 4.0A)
None
J01  A 600 (-3.4A)
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
 0.69A 4euzA-2xfsA:
21.5		 4euzA-2xfsA:
23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FOG_A_C2FA302_0
(THYMIDYLATE SYNTHASE)		 2xfs ORF12
(Streptomyces
clavuligerus) 		5 / 11 ILE A 420
TRP A 387
LEU A 362
GLY A 414
PHE A 416
 None
None
None
J01  A 600 ( 4.7A)
None
 1.28A 4fogA-2xfsA:
undetectable		 4fogA-2xfsA:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6C79_A_CE3A301_1
(BETA-LACTAMASE
TOHO-1)		 2xfs ORF12
(Streptomyces
clavuligerus) 		6 / 12 ALA A 173
SER A 234
ASN A 236
LYS A 375
GLY A 377
SER A 378
 J01  A 600 ( 4.0A)
J01  A 600 (-3.4A)
None
J01  A 600 ( 4.4A)
J01  A 600 ( 3.8A)
J01  A 600 (-3.4A)
 0.32A 6c79A-2xfsA:
23.0		 6c79A-2xfsA:
9.69